Compare AstraZeneca plc (AZN) vs SoFi Technologies Inc (SOFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs SoFi Technologies Inc — how do they compare? AstraZeneca plc trades at $158.11 (market cap $248.14B), while SoFi Technologies Inc trades at $18.11 (market cap $23.22B). The key difference: AstraZeneca plc is far larger — about 10.7× SoFi Technologies Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals.
| AZN | SOFI | |
|---|---|---|
Market Cap | $248.14B | $23.22B |
Sector | Health | Financials |
52-Week High | $209.48 | $32.21 |
52-Week Low | $147.06 | $15.15 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About SoFi Technologies Inc
SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →
